The Food and Drug Administration issued a warning in July 2011 that patients who received a transvaginal mesh device may face a greater risk of complications than those who received other forms of treatment. Transvaginal surgical mesh products are used to treat patients with pelvic organ prolapse (POP) and stress urinary incontinence (SUI). This document contains a list of transvaginal mesh manufacturers and the surgical mesh devices sold by their companies.